Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.06% Nasdaq Down 0.72%
Streaming
Ticker Tape: On

Protalix BioTherapeutics, Inc. (PLX)

-NYSE MKT
4.14 Down 0.06(1.43%) 1:07PM EDT
Get the big picture on all your investments.
Prev Close:4.20
Open:4.22
Bid:4.14 x 500
Ask:4.15 x 4800
1y Target Est:6.40
Beta:1.37
Earnings Date:May 5 - May 9 (Est.)
Day's Range:4.09 - 4.22
52wk Range:3.70 - 5.81
Volume:38,038
Avg Vol (3m):215,792
Market Cap:383.28M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PLX

Comparison

Symbol% ChgMkt Cap
PLXDown 1.43%383.28M
SHPGUp 2.95%30.62B

Key Statistics

Forward P/E (1 yr):46.00
P/S (ttm):33.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.03
Quarterly EPS Est (Mar-14) :-0.04
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-5.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression sy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback